115 related articles for article (PubMed ID: 6772663)
1. Graves' disease associated with elevated serum thyroxine-binding globulin concentrations.
Yabu Y; Amino N; Nakatani K; Ichihara K; Azukizawa M; Miyai K
J Clin Endocrinol Metab; 1980 Aug; 51(2):325-9. PubMed ID: 6772663
[No Abstract] [Full Text] [Related]
2. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
[TBL] [Abstract][Full Text] [Related]
3. The relationship of thyroxine turnover to other parameters of peripheral thyroid function in Graves' disease.
Clifton-Bligh P; Burke G
J Lab Clin Med; 1975 Jun; 85(6):922-33. PubMed ID: 48532
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients.
Tamai H; Hayaki I; Kawai K; Komaki G; Matsubayashi S; Kuma K; Kumagai LF; Nagataki S
J Clin Endocrinol Metab; 1995 May; 80(5):1481-4. PubMed ID: 7744989
[TBL] [Abstract][Full Text] [Related]
5. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of elevated serum triiodothyronine to thyroxine ratios in patients with Graves' disease treated with antithyroid drugs].
Takamatsu J
Nihon Naibunpi Gakkai Zasshi; 1983 Mar; 59(3):295-303. PubMed ID: 6190686
[No Abstract] [Full Text] [Related]
7. Factors influencing the relationship between labelled triiodothyronine and thyroxine levels in the serum of patients with Graves' disease.
Földes J; Gyertyánfy G; Tako J; Bános C; Gesztesi E
Endokrinologie; 1973 Jan; 61(1):52-64. PubMed ID: 4739850
[No Abstract] [Full Text] [Related]
8. Serum free thyroxine and triiodothyronine concentrations in subacute thyroiditis.
Yoshida K; Sakurada T; Kaise N; Kaise K; Kitaoka H; Fukazawa H; Yamamoto M; Saito S; Yoshinaga K
J Clin Endocrinol Metab; 1982 Jul; 55(1):185-8. PubMed ID: 6176591
[TBL] [Abstract][Full Text] [Related]
9. Unresponsiveness to thyrotropin-releasing hormone (TRH) in treated Graves' hyperthyroidism and in euthyroid Graves' disease.
Clifton-Bligh P; Silverstein GE; Burke G
J Clin Endocrinol Metab; 1974 Apr; 38(4):531-8. PubMed ID: 4206830
[No Abstract] [Full Text] [Related]
10. A case of total thyroxine-binding globulin deficiency with Graves' disease: fluctuations of plasma triiodothyronine/thyroxine ratio.
Kamikubo K; Kojima N; Yamakita N; Miura K
Jpn J Med; 1986 May; 25(2):186-90. PubMed ID: 3091890
[TBL] [Abstract][Full Text] [Related]
11. Inappropriate suppression of thyrotropin during medical treatment of Graves disease in childhood.
Sills IN; Horlick MN; Rapaport R
J Pediatr; 1992 Aug; 121(2):206-9. PubMed ID: 1640284
[TBL] [Abstract][Full Text] [Related]
12. Neonatal Graves' Eye Disease.
Segal KL; Nelson CC
Ophthalmology; 2017 May; 124(5):673. PubMed ID: 28433126
[No Abstract] [Full Text] [Related]
13. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
[TBL] [Abstract][Full Text] [Related]
14. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
[TBL] [Abstract][Full Text] [Related]
15. Serum ferritin, iron and transferrin in women with thyrotoxic Graves' disease before and after methimazole treatment.
Zwirska-Korczala K; Buntner B; Sobieraj H; Ostrowska Z; Kniazewski B; Swietochowska E
Acta Physiol Pol; 1990; 41(7):163-8. PubMed ID: 2136311
[TBL] [Abstract][Full Text] [Related]
16. [Behavior of the levels of free triiodothyronine, triiodothyronine, free thyroxine, thyroxine, thyrotropin and thyroxine-binding globulin in the serum of children with nephrotic syndrome].
Liappis N; Rao GS
Klin Padiatr; 1985; 197(5):423-6. PubMed ID: 3934459
[TBL] [Abstract][Full Text] [Related]
17. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
18. Correlation between thyroid stimulators and 3,5,3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin-displacing activities.
Kuzuya N; Chiu SC; Ikeda H; Uchimura H; Ito K; Nagataki S
J Clin Endocrinol Metab; 1979 Apr; 48(4):706-11. PubMed ID: 581876
[No Abstract] [Full Text] [Related]
19. An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease.
Yamada T; Sato A; Komiya I; Nishimori T; Ito Y; Terao A; Eto S; Tanaka Y
J Clin Endocrinol Metab; 2000 Aug; 85(8):2775-8. PubMed ID: 10946880
[TBL] [Abstract][Full Text] [Related]
20. Decreased secretion of gonadotropins in a patient with Graves' disease.
Hakamata M; Itoh M; Sudo Y; Katada E; Miyata N
Exp Clin Endocrinol Diabetes; 1996; 104(1):85-8. PubMed ID: 8750576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]